Abstract:ObjectiveTo investigate the risk factors for early recurrence of resectable pancreatic cancer and the establishment and application of a grading system. MethodsA retrospective case-control study was conducted among 303 patients with resectable pancreatic cancer who underwent radical resection in Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, from March 2015 to June 2021, and according to the presence or absence of early recurrence (within 6 months after surgery), the 283 patients directly operated on were divided into early recurrence group with 95 patients and non-early recurrence group with 188 patients; 20 patients who received neoadjuvant therapy before surgery were enrolled as neoadjuvant therapy group. Observation indicators included general information, preoperative imaging data, preoperative laboratory data, routine blood test/blood biochemistry and derived indicators, tumor markers, and coagulation markers, and follow-up was conducted to observe recurrence-free survival. The t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups; the chi-square test was used for comparison of categorical data between two groups. A multivariate Logistic regression analysis was used to investigate the risk factors for early recurrence in patients with pancreatic cancer, and the receiver operating characteristic (ROC) curve was used to determine the optimal cut-off value of each indicator. The Kaplan-Meier curve was plotted, and the Log-rank test was used for comparison of recurrence-free survival time between groups. Results The univariate analysis showed that compared with the non-early recurrence group, the early recurrence group had significantly lower body mass index (BMI) and triglyceride and significantly higher CA19-9, CA242, CA125, and plasma fibrinogen (all P＜0.05). The multivariate logistic regression analysis showed that BMI (odds ratio ［OR］=1.150, 95% confidence interval ［CI］: 1.038-1.273, P=0.007), plasma fibrinogen (OR=2.513, 95%CI: 1.355-4.663, P=0.003), and CA242 (OR=2.482, 95%CI: 1.067-5.774, P=0.035) were independent risk factors for early recurrence in patients with resectable pancreatic cancer. BMI, CA242, and plasma fibrinogen were included in the grading system, with a cut-off value of 23.00 kg/m2, 30.0 U/mL, and 4.00 g/L, respectively. BMI＜23.00 kg/m2 was counted as 1 point, otherwise it was counted as 0 point; CA242≥30.00 U/mL was counted as 1 point, otherwise it was counted as 0 point; plasma fibrinogen ≥4.00 g/L was counted as 1 point, otherwise it was counted as 0 point; the total score was 0-3 points. The patients in both the early recurrence group and the non-early recurrence group were scored, and the results showed that the early recurrence group had a significantly higher score than the non-early recurrence group ［2(0-3) points vs 1(0-3) point, Z=-5.339, P＜0.001］. The Kaplan-Meier curve analysis showed that there was a significant difference in time to recurrence between groups (χ2=28.116, P＜0.001), and the higher the score, the shorter the expected time to recurrence. The patients with 3 points were defined as high-risk group and those with 0-2 points were defined as low-risk group, and the early recurrence rate was 84.6% in the high-risk group and 31.2% in the low-risk group. ConclusionThe grading system based on BMI, plasma fibrinogen, and CA242 can reliably predict postoperative recurrence.

Effect of Risk Factor Score on Early Recurrence After Pancreatectomy for Invasive Pancreatic Ductal Adenocarcinoma

Recurrence Scoring System Predicting Early Recurrence for Patients with Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy and Portomesenteric Vein Resection

Recurrence and Survival Prediction Models for Receiving Preoperative Chemotherapy Pancreatic Ductal Adenocarcinoma Cancer: A Single-center Retrospective Research

Prediction of early recurrence of pancreatic ductal adenocarcinoma after resection

Risk Factors Influencing Recurrence Following Resection of Pancreatic Head Cancer.

Predicting Recurrence-Free Survival After Upfront Surgery in Resectable Pancreatic Ductal Adenocarcinoma: A Preoperative Risk Score Based on CA 19-9, CT, and 18F-FDG PET/CT

Establishment and Application of a Preoperative Grading System for Resectable Pancreatic Cancer

Postoperative Serum Tumor Markers-Based Nomogram Predicting Early Recurrence for Patients Undergoing Radical Resections of Pancreatic Ductal Adenocarcinoma

Recurrence pattern and its risk factors in patients with resected pancreatic ductal adenocarcinoma - A retrospective analysis of 272 patients

A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma

Nomogram model for predicting early recurrence for resectable pancreatic cancer: A multicenter study

Factors predicting recurrence after left‑sided pancreatectomy for pancreatic ductal adenocarcinoma

Predicting early recurrence for resected pancreatic ductal adenocarcinoma: a multicenter retrospective study in China

The prognosis-based classification model in resectable pancreatic cancer

Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer

Nomogram and Competing Risk Model to Predict Recurrence after Curative Surgical Resection of PDAC

Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Ductal Adenocarcinoma

A predictive model for recurrence after upfront surgery in patients with resectable pancreatic ductal adenocarcinoma (PDAC) by using preoperative clinical data and CT characteristics

Early Recurrence in Resected Gallbladder Carcinoma: Clinical Impact and Its Preoperative Predictive Score

Preoperative Recurrence Prediction in Pancreatic Ductal Adenocarcinoma after Radical Resection Using Radiomics of Diagnostic Computed Tomography

Uncovering the clinicopathological features of early recurrence after surgical resection of pancreatic cancer